Differential regulation of the mannose and SP-A receptors on macrophages

被引:55
作者
Chroneos, Z
Shepherd, VL
机构
[1] VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37212 USA
[2] VANDERBILT UNIV, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37212 USA
[3] DEPT VET AFFAIRS MED CTR, NASHVILLE, TN 37212 USA
关键词
surfactant-associated protein A; mannose receptor;
D O I
10.1152/ajplung.1995.269.6.L721
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Two carbohydrate-dependent mechanisms exist on alveolar macrophages to clear mannose-containing pathogens: receptor-mediated entry of non-opsonized microorganisms via the mannose receptor and receptor recognition of pathogens opsonized with surfactant-associated protein A (SP-A). A number of studies have demonstrated that mannose receptor expression is tightly linked to the functional state of the macrophage. In the present study, we investigated regulation of binding of SP-A to its receptor on macrophages by the same agents that regulate mannose-receptor expression. Phorbol 12-myristate 18-acetate, lipopolysaccharide (LPS), and interferon-gamma treatment of rat marrow-derived macrophages increased SP-A binding by 163, 296, and 337%, respectively, over untreated controls. Mannose-receptor activity was reduced to 75, 60, and 25% of control levels by these agents. Dexamethasone increased mannose receptor activity to 225%, while decreasing SP-A binding to 44% of controls. Addition of granulocyte macrophage-colony stimulating factor (GM-CSF) to human monocytes on day 0 dramatically increased mannose-receptor activity on day 5 over the non-serum control. SP-A binding was highest to freshly isolated monocytes and decreased to < 10% after differentiation in the presence of GM-CSF. After intraperitoneal injection of dexamethasone, rat alveolar macrophages isolated at 24 h expressed increased mannose-receptor activity and decreased SP-A binding. LPS injection resulted in increased SP-A binding and decreased mannose-receptor activity. In every instance, SP-A binding was inversely regulated with respect to mannose-receptor expression. We therefore speculate that the mannose receptor is a first-line host-defense receptor that is turned off during inflammation. SP-A. in the alveolar space can then act as a lung-specific opsonin and mediate clearance of pathogens via the upregulated SP-A receptor.
引用
收藏
页码:L721 / L726
页数:6
相关论文
共 36 条
  • [1] INTERFERON-GAMMA AND SYNTHESIS OF SURFACTANT COMPONENTS BY CULTURED HUMAN FETAL LUNG
    BALLARD, PL
    LILEY, HG
    GONZALES, LW
    ODOM, MW
    AMMANN, AJ
    BENSON, B
    WHITE, RT
    WILLIAMS, MC
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 2 (02) : 137 - 143
  • [2] INTERACTION OF MYCOBACTERIUM-AVIUM COMPLEX WITH HUMAN MACROPHAGES - ROLES OF MEMBRANE-RECEPTORS AND SERUM-PROTEINS
    BERMUDEZ, LE
    YOUNG, LS
    ENKEL, H
    [J]. INFECTION AND IMMUNITY, 1991, 59 (05) : 1697 - 1702
  • [3] DEXAMETHASONE UP-REGULATES MANNOSE RECEPTOR ACTIVITY BY INCREASING MESSENGER-RNA LEVELS
    COWAN, HB
    VICK, S
    CONARY, JT
    SHEPHERD, VL
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 296 (01) : 314 - 320
  • [4] INVOLVEMENT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PULMONARY HOMEOSTASIS
    DRANOFF, G
    CRAWFORD, AD
    SADELAIN, M
    REAM, B
    RASHID, A
    BRONSON, RT
    DICKERSIN, GR
    BACHURSKI, CJ
    MARK, EL
    WHITSETT, JA
    MULLIGAN, RC
    [J]. SCIENCE, 1994, 264 (5159) : 713 - 716
  • [5] DRICKAMER K, 1988, J BIOL CHEM, V263, P9557
  • [6] UPTAKE OF PNEUMOCYSTIS-CARINII MEDIATED BY THE MACROPHAGE MANNOSE RECEPTOR
    EZEKOWITZ, RAB
    WILLIAMS, DJ
    KOZIEL, H
    ARMSTRONG, MYK
    WARNER, A
    RICHARDS, FF
    ROSE, RM
    [J]. NATURE, 1991, 351 (6322) : 155 - 158
  • [7] POSTNATAL STIMULATION OF RAT SURFACTANT PROTEIN-A SYNTHESIS BY DEXAMETHASONE
    FLOROS, J
    PHELPS, DS
    HARDING, HP
    CHURCH, S
    WARE, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02): : L137 - L143
  • [8] HARRIS N, 1992, BLOOD, V80, P2363
  • [9] JACK RM, 1994, J IMMUNOL, V153, P262
  • [10] KARBASSI A, 1987, J IMMUNOL, V139, P417